AKAP9 anticorps (AA 1075-1125)

N° du produit ABIN7451618

L’anticorps anti-AKAP9 Polyclonal Lapin est utilisé pour la détection de AKAP9 dans des échantillons de Humain. Il a été validé pour WB et IP.

Aperçu rapide pour AKAP9 anticorps (AA 1075-1125) (ABIN7451618)

Antigène: AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AKAP9 est non-conjugé

Application: Western Blotting (WB), Immunoprecipitation (IP)

Détail du produit anti-AKAP9 anticorps

Épitope: AA 1075-1125

Fonction: Rabbit anti-AKAP9/CG-NAP Antibody, Affinity Purified

Purification: Affinity Purified

Immunogène: between AA 1075 and 1125

Isotype: IgG

Information d'application

Indications d'application:

IP: 2 - 5 μg/mg lysate

WB: 1:2,000 - 1:10,000

Restrictions: For Research Use only

Stockage

Concentration: 1000 μg/mL

Buffer: Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Date de péremption: 12 months

Détails sur AKAP9

Antigène: AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))

Autre désignation: AKAP9/CG-NAP

Sujet: Background: AKAP9/CG-NAP is a member of the A-kinase anchoring protein family that functions as a molecular scaffold for the subcellular compartmentalization of A- kinase signaling molecules. AKAP9/CG-NAP has been found to be critical to repolarization in the human heart. Defects in AKAP9/CG-NAP result in long QT syndrome type 11, a heart disorder characterized by ventricular arrhythmia and prolonged QT intervals. AKAP9/CG-NAP has been shown to form a multiprotein complex with the I(Ks) potassium channel subunit and play an essential role in its phosphorylation by PKA. AKAP9/CG-NAP is also important to centrosome and microtubule cytoskeletal organization.

ID gène: 10142

NCBI Accession: NP_671700

UniProt: Q99996

Pathways: M Phase, SARS-CoV-2 Protein Interactome